Abstract:Human APOBEC3G exhibits anti-human immunodeficiency virus-1 (HIV-1) activity by deaminating cytidines of the minus strand of HIV-1. Here, we report a solution structure of the C-terminal deaminase domain of wild-type APOBEC3G. The interaction with DNA was examined. Many differences in the interaction were found between the wild type and recently studied mutant APOBEC3Gs. The position of the substrate cytidine, together with that of a DNA chain, in the complex, was deduced. Interestingly, the deamination reacti… Show more
“…The structures of the individual domains are very similar to those of other cytidine deaminases and are characterized by a fivestranded mixed beta sheet and five alpha helices. The current CTD of our model is not substantially different from the CTD structures that were recently determined by X-ray crystallography and NMR (32,(37)(38)(39). Since we created and used our homology model to guide the current mutagenesis, several other models of A3G have become available (40,41).…”
During coevolution with the host, HIV-1 developed the ability to hijack the cellular ubiquitin/proteasome degradation pathway to counteract the antiviral activity of APOBEC3G (A3G), a host cytidine deaminase that can block HIV-1 replication. Abrogation of A3G function involves the HIV-1 Vif protein, which binds A3G and serves as an adapter molecule to recruit A3G to a Cullin5-based E3 ubiquitin ligase complex. Structure-guided mutagenesis of A3G focused on the 14 most surface-exposed Lys residues allowed us to identify four Lys residues (Lys-297, 301, 303, and 334) that are required for Vif-mediated A3G ubiquitination and degradation.
“…The structures of the individual domains are very similar to those of other cytidine deaminases and are characterized by a fivestranded mixed beta sheet and five alpha helices. The current CTD of our model is not substantially different from the CTD structures that were recently determined by X-ray crystallography and NMR (32,(37)(38)(39). Since we created and used our homology model to guide the current mutagenesis, several other models of A3G have become available (40,41).…”
During coevolution with the host, HIV-1 developed the ability to hijack the cellular ubiquitin/proteasome degradation pathway to counteract the antiviral activity of APOBEC3G (A3G), a host cytidine deaminase that can block HIV-1 replication. Abrogation of A3G function involves the HIV-1 Vif protein, which binds A3G and serves as an adapter molecule to recruit A3G to a Cullin5-based E3 ubiquitin ligase complex. Structure-guided mutagenesis of A3G focused on the 14 most surface-exposed Lys residues allowed us to identify four Lys residues (Lys-297, 301, 303, and 334) that are required for Vif-mediated A3G ubiquitination and degradation.
“…4). A reduction in activity compared with WT AID begins to be apparent for ⌬C 17 , is much more pronounced for ⌬C 18 , and activity is abolished for ⌬C 19 and ⌬C 20 (Fig. 2, D and E).…”
Section: Structural Evaluation Of Higm-2 Point Mutants and C-terminalmentioning
confidence: 99%
“…Four other structures (three NMR and one crystal) of Apo3G-CD2 have also been solved (17)(18)(19)(20). Apo2 and Apo3G-CD2 show substantial overlap of an overall core structure containing a five -strand sheet surrounded by six ␣-helices.…”
Section: Structural Evaluation Of Higm-2 Point Mutants and C-terminalmentioning
confidence: 99%
“…High resolution structures of the deaminase domain of APOBEC enzymes have been determined for Apo2 (16) and for the C-terminal catalytic domain (CD2) of Apo3G (17)(18)(19)(20). Overall, these structures showed a highly conserved deaminase domain with a five-stranded -sheet core flanked by six ␣-helices (Fig.…”
Background: HIGM-2 syndrome results from mutations spanning AID. Results: AID mutations are characterized biochemically and analyzed using a surrogate Apo3G structure. Conclusion: Catalytically active mutants retain salient enzymatic properties of WT AID; catalytically inactive mutants retain salient ssDNA binding properties of WT AID. Significance: We identify four structural classes of mutants and discuss the catalytic consequences of each mutation.
“…S1). However, the CD2 domain does not contain the hydrophobic residues conserved in CD1 and Apo2; these residues have previously been shown to be involved in substrate specificity (29,36,37). The Apo3G C-mutant (23% monomer, 65% dimer, Fig.…”
Section: Mals Analysis Of the Oligomerization State Of Native And Mutmentioning
APOBEC3G (Apo3G) is a single-stranded DNA-dependent deoxycytidine deaminase, which, in the absence of the human immunodeficiency virus (HIV) viral infectivity factor, is encapsulated into HIV virions. Subsequently, Apo3G triggers viral inactivation by processively deaminating C3 U, with 335 polarity, on nascent minus-strand cDNA. Apo3G has a catalytically inactive N-terminal CD1 domain and an active C-terminal CD2 domain. Apo3G exists as monomers, dimers, tetramers, and higher order oligomers whose distributions depend on DNA substrate and salt. Here we use multiangle light scattering and atomic force microscopy to identify oligomerization states of Apo3G. A double mutant (F126A/W127A), designed to disrupt dimerization at the predicted CD1-CD1 dimer interface, predominantly converts Apo3G to a monomer that binds singlestranded DNA, Alu RNA, and catalyzes processive C3 U deaminations with 335 deamination polarity, similar to native Apo3G. The CD1 domain is essential for both processivity and polarity. We propose a structure-based model to explain the scanning and catalytic behavior of Apo3G.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.